News - Pharmaceutical Technology https://www.pharmaceutical-technology.com/news/ The leading site for news and procurement in the pharmaceutical industry Thu, 22 Aug 2024 16:20:23 +0000 en-US hourly 1 https://wordpress.org/?v=6.6.1 https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2022/01/cropped-Pharmaceutical-Technology-Favicon-150x150.png News - Pharmaceutical Technology https://www.pharmaceutical-technology.com/news/ 32 32 Eisai’s Leqembi deemed too costly for NHS https://www.pharmaceutical-technology.com/news/eisais-leqembi-deemed-too-costly-for-nhs/ Thu, 22 Aug 2024 16:17:02 +0000 https://www.pharmaceutical-technology.com/news/eisais-leqembi-deemed-too-costly-for-nhs/ Lexicon to face FDA AdComm for Zynquista approval in diabetes and CKD https://www.pharmaceutical-technology.com/news/lexicon-to-face-fda-adcomm-for-zynquista-approval-in-diabetes-and-ckd/ Thu, 22 Aug 2024 13:42:44 +0000 https://www.pharmaceutical-technology.com/news/lexicon-to-face-fda-adcomm-for-zynquista-approval-in-diabetes-and-ckd/ Leo Pharma’s Timber bet falls flat following Phase III failure https://www.pharmaceutical-technology.com/news/leo-pharmas-timber-bet-falls-flat-following-phase-iii-failure/ Thu, 22 Aug 2024 11:31:44 +0000 https://www.pharmaceutical-technology.com/uncategorized/leo-pharmas-timber-bet-falls-flat-following-phase-iii-failure/ CTI announces partnership for oncology drug development https://www.pharmaceutical-technology.com/news/cti-oncology-drug-development/ Thu, 22 Aug 2024 10:30:26 +0000 https://www.pharmaceutical-technology.com/news/cti-oncology-drug-development/ Touchlight to supply GMP dbDNA for UK Zika vaccine study https://www.pharmaceutical-technology.com/news/touchlight-dbdna-zika-uk/ Thu, 22 Aug 2024 10:13:20 +0000 https://www.pharmaceutical-technology.com/news/touchlight-dbdna-zika-uk/ Innovent’s Dupert approved in China to treat lung cancer https://www.pharmaceutical-technology.com/news/innovents-china-treatment/ Thu, 22 Aug 2024 08:30:35 +0000 https://www.pharmaceutical-technology.com/news/innovents-china-treatment/ FDA accepts BMS’ sBLA for Opdivo-Yervoy combo for HCC https://www.pharmaceutical-technology.com/news/fda-sbla-opdivo-yervoy-hcc/ Thu, 22 Aug 2024 08:25:10 +0000 https://www.pharmaceutical-technology.com/news/fda-sbla-opdivo-yervoy-hcc/ Pathalys secures $105m to advance SHPT drug through approval https://www.pharmaceutical-technology.com/news/pathalys-secures-105m-to-advance-shpt-drug-through-approval/ Wed, 21 Aug 2024 19:10:05 +0000 https://www.pharmaceutical-technology.com/news/pathalys-secures-105m-to-advance-shpt-drug-through-approval/ FDA declines to approve Regeneron’s linvoseltamab amid manufacturing issues https://www.pharmaceutical-technology.com/news/fda-declines-to-approve-regenerons-linvoseltamab-amid-manufacturing-issues/ Wed, 21 Aug 2024 16:09:52 +0000 https://www.pharmaceutical-technology.com/news/fda-declines-to-approve-regenerons-linvoseltamab-amid-manufacturing-issues/ Emergent BioSolutions finalises manufacturing site sale to Bora Pharmaceuticals https://www.pharmaceutical-technology.com/news/emergent-biosolutions-finalises-manufacturing-site-sale-to-bora-pharmaceuticals/ Wed, 21 Aug 2024 15:09:46 +0000 https://www.pharmaceutical-technology.com/news/emergent-biosolutions-finalises-manufacturing-site-sale-to-bora-pharmaceuticals/